161 related articles for article (PubMed ID: 33718136)
1. Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer.
Wei KL; Chou JL; Chen YC; Low JT; Lin GL; Liu JL; Chang TS; Chen WM; Hsieh YY; Yan PS; Chuang YM; Lin JMJ; Wu SF; Chiang MK; Li C; Wu CS; Chan MWY
Front Oncol; 2021; 11():575667. PubMed ID: 33718136
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
3. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
[TBL] [Abstract][Full Text] [Related]
4. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
[TBL] [Abstract][Full Text] [Related]
5. Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
Tran MTMT; Yeh KT; Chuang YM; Hsu PY; Low JT; Kumari H; Lee YT; Chen YC; Huang WH; Jin H; Lin SH; Chan MWY
PLoS One; 2021; 16(4):e0250499. PubMed ID: 33886682
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
7. Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.
Li Z; Li D; Zhang G; Xiong J; Jie Z; Cheng H; Cao Y; Jiang M; Lin L; Le Z; Tan S; Zou W; Gong B; Lin S; Yang K
Am J Cancer Res; 2014; 4(6):648-62. PubMed ID: 25520857
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
9. Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines.
Wang J; Yang B; Han L; Li X; Tao H; Zhang S; Hu Y
Cell Physiol Biochem; 2013; 32(6):1707-19. PubMed ID: 24356455
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
11. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness.
Cheng FHC; Lin HY; Hwang TW; Chen YC; Huang RL; Chang CB; Yang W; Lin RI; Lin CW; Chen GCW; Mai SY; Lin JMJ; Chuang YM; Chou JL; Kuo LW; Li C; Cheng ASL; Lai HC; Wu SF; Tsai JC; Chan MWY
Cancer Sci; 2019 Mar; 110(3):1085-1095. PubMed ID: 30582655
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-143 suppresses the proliferation and metastasis of human gastric cancer cells via modulation of STAT3 expression.
Wu Y; Wan X; Zhao X; Song Z; Xu Z; Tao Y; Sun C
Am J Transl Res; 2020; 12(3):867-874. PubMed ID: 32269719
[TBL] [Abstract][Full Text] [Related]
13. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
15. miR-193a Directly Targets PSEN1 and Inhibits Gastric Cancer Cell Growth, the Activation of PI3K/Akt Signaling Pathway, and the Epithelial-to-Mesenchymal Transition.
Pan X; Zhao T; Mu S; Li S
J Oncol; 2021; 2021():2804478. PubMed ID: 34335753
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.
Grossi I; Arici B; Portolani N; De Petro G; Salvi A
Oncotarget; 2017 Jan; 8(4):6955-6969. PubMed ID: 28036298
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis.
Chi J; Liu T; Shi C; Luo H; Wu Z; Xiong B; Liu S; Zeng Y
Biomed Pharmacother; 2019 Oct; 118():109201. PubMed ID: 31545227
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.
Li D; Li Z; Xiong J; Gong B; Zhang G; Cao C; Jie Z; Liu Y; Cao Y; Yan Y; Xiong H; Qiu L; Yang M; Chen H; Jiang S; Yang X; Chen H
Am J Cancer Res; 2015; 5(10):2980-97. PubMed ID: 26693054
[TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
20. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
